Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
02/24/1999 | CN1209170A Novel DNA polymerase |
02/24/1999 | CN1209169A Process for microbial prodn. of amino acid by boosted activity of export carriers |
02/24/1999 | CN1209167A Human chemokine polypeptides |
02/24/1999 | CN1209166A Fungal food |
02/24/1999 | CN1209068A Hyaluronic acid as DNA carrier for gene therapy and VEGF antisense DNA to treat abnormal retinal vascularization |
02/24/1999 | CN1209038A Mold-resistant plant and process for producing same |
02/24/1999 | CN1208771A High effect expressing carrier for animal mammary gland tissue specificity |
02/24/1999 | CN1208770A Lumbrical fibrinolysin gene nucleotide series, and method for clone of same |
02/24/1999 | CN1208769A Synthesis and clone of composite polyvalent vaccine gene for type-C hepatitis virus |
02/24/1999 | CN1208768A Consensus phytases |
02/24/1999 | CN1208731A Recombination human alpha type composite interferon, prepn. method and use therefor |
02/24/1999 | CN1208730A Prodn. of human growth hormone by using animal mamma as raw material |
02/24/1999 | CN1208600A Method for producing transfer-gene animals by using sperm dielectric transfer DNA |
02/23/1999 | US5874662 Method for producing somoclonal variant cotton plants |
02/23/1999 | US5874626 Osmotin gene promoter and use thereof |
02/23/1999 | US5874567 Therapeutic oligonucleotides targeting the human MDR1 and MRP genes |
02/23/1999 | US5874566 Il-15 triplex oligonucleotides |
02/23/1999 | US5874565 Nucleic acids comprising a highly conserved novel 3 terminal sequence element of the hepatitis C virus |
02/23/1999 | US5874562 Nucleic acid encoding developmentally-regulated endothelial cell locus-1 |
02/23/1999 | US5874561 DNA, host cell and vector encoding a protein with cytokine inhibitory activity |
02/23/1999 | US5874560 Melanoma antigens and their use in diagnostic and therapeutic methods |
02/23/1999 | US5874558 Vector system; greater glycosylation, improved thermostability |
02/23/1999 | US5874557 Enzyme inhibitors which bind to polymerases at ambient temperatures and prevent amplification of nontarget oligonucleotides during polymerase chain reactions; for accurate diagnosis |
02/23/1999 | US5874556 Hybrid genes for use in the production of TH -independent cytotoxic T cells |
02/23/1999 | US5874546 Genetically engineered protein having specific amino acid sequence |
02/23/1999 | US5874545 DCC antibodies |
02/23/1999 | US5874544 Antibodies to APO(A) |
02/23/1999 | US5874542 Single chain antibodies specific to VEGF receptors |
02/23/1999 | US5874541 Immunoglobulin or fragment is modified such that heavy chain variable region have been replaced by specific sequence or amino acids of a heavy chain immunogloblin comprising two heavy polypeptide chain consisting of antigen binding site |
02/23/1999 | US5874540 CDR-grafted type III anti-CEA humanized mouse monoclonal antibodies |
02/23/1999 | US5874539 Antibodies to nuclear matrix proteins |
02/23/1999 | US5874536 Proteins with Oncostatin M activity and process for their preparation |
02/23/1999 | US5874535 Human leptin receptor gene-related protein |
02/23/1999 | US5874534 Mutated steroid hormone receptors, methods for their use and molecular switch for gene therapy |
02/23/1999 | US5874533 HIV-2 envelope polypeptides |
02/23/1999 | US5874527 Plasmodium vivax blood stage antigens |
02/23/1999 | US5874526 Toxoplasma gondii antigens |
02/23/1999 | US5874416 Antitumor |
02/23/1999 | US5874415 Enhancer sequence for modulating expression in epithelial cells |
02/23/1999 | US5874414 Trans-splicing ribozymes |
02/23/1999 | US5874409 Antiphospholipid analog specifically binds antibodies produced by b cells specific for an antiphospholipid epitope and lacks t cell epitopes; where in the analog is a oligopeptide or polypeptide |
02/23/1999 | US5874406 Synthetic peptide analogs of lung surface protein SP-C |
02/23/1999 | US5874404 Immunoglobulin E receptor α-chain inhibits IgE production and secondary allergic responses |
02/23/1999 | US5874400 Recombinant C140 receptor, its agonists and antagonists, and nucleic acids encoding the receptor |
02/23/1999 | US5874399 Progenitor B cell stimulating factor |
02/23/1999 | US5874308 A first member of a specific binding pair and a conjugate comprising a second member of said specific binding pair and an amino acid sequence comprising a substrate binding region derived from a polysaccharidase |
02/23/1999 | US5874304 Humanized green fluorescent protein genes and methods |
02/23/1999 | US5874300 Campylobacter jejuni antigens and methods for their production and use |
02/23/1999 | US5874299 Transgene coding for human immunoglobulin heavy chain variable regions, d regions, j regions, mu constant region, and gamma constant region where gamma region is closer to mu region than in natural locus |
02/23/1999 | US5874298 Wasp neurotoxin for controlling heliothis virescens (tobacco budworm); fast acting, insects stop feeding quickly; low toxicity to mammals; host cells and vectors expressing toxin |
02/23/1999 | US5874297 Treatment of genetic disorders |
02/23/1999 | US5874293 Adding endoglucanase type components to a composition to produce a treatment medium; treating said material with said treatment medium |
02/23/1999 | US5874288 Bacillus thuringiensis toxins with improved activity |
02/23/1999 | US5874287 Mutagenized DNA molecules encoding modified subunit a of Cholera-toxin |
02/23/1999 | US5874286 Tumor proteins |
02/23/1999 | US5874282 Genetic engineered dna encodes a thermostable dna polymerase protein for use in nucleic acid sequencing, nucleic acid amplification |
02/23/1999 | US5874281 Suppressing human immunodeficiency virus in cultured cells by incubating with targeted oligonucleotide and truncated subtargeted oligonucleotide for synergistic antisense therapy |
02/23/1999 | US5874280 Mutant comprising insertion of heterologous dna sequence in section of bhv-1 genome and inserted polyadenylation signal |
02/23/1999 | US5874279 Recombinant infectious bovine rhinotracheitis virus |
02/23/1999 | US5874278 Protease deletion |
02/23/1999 | US5874277 Proteins, their production and use |
02/23/1999 | US5874276 Cellulase enzymes and systems for their expressions |
02/23/1999 | US5874275 Nucleic acid sequences, vectors and cells |
02/23/1999 | US5874273 Nucleic acids for encoding genes and amino acid sequences and hybridization and nucleotide sequences |
02/23/1999 | US5874269 Prevention of synthesis of specific enzymes in the pathway for ethylene biosynthesis |
02/23/1999 | US5874268 Method of introducing exogenous compounds into cells by electroporation and apparatus for same |
02/23/1999 | US5874267 Expression of surface layer proteins |
02/23/1999 | US5874265 Methods and compositions for the production of stably transformed fertile monocot plants and cells thereof |
02/23/1999 | US5874264 Retrovirus |
02/23/1999 | US5874259 Bacterial artificial chromosome comprising site into which dna fragment can be cloned, a pair of inducible excision-mediating sites flanking the site into which the dna fragment can be cloned |
02/23/1999 | US5874255 DNA encoding humanized antibodies specific for the ganglioside GM2 |
02/23/1999 | US5874254 FGF-5 analogous protein, and pharmaceutical composition containing the same |
02/23/1999 | US5874253 Expression vectors and genetic engineering |
02/23/1999 | US5874252 Splicing variant of the Epstein-Barr virus-induced G-protein coupled receptor |
02/23/1999 | US5874251 DNA encoding the Taenia crassiceps ten kilodalton antigen |
02/23/1999 | US5874250 DNA encoding for a protein containing the extracellular domain of lymphocyte activation gene 3 |
02/23/1999 | US5874247 Protein disulfide isomerase and method of using |
02/23/1999 | US5874245 Human G-protein coupled receptor (HIBCD07) |
02/23/1999 | US5874244 Human NADH dehydrogenase subunits and DNA thereof |
02/23/1999 | US5874243 OLRCC15 receptor |
02/23/1999 | US5874242 Efficient translation in eukaryotic and prokaryotic systems |
02/23/1999 | US5874240 Human 4-1BB receptor splicing variant |
02/23/1999 | US5874239 Biotinylation of proteins |
02/23/1999 | US5874236 DNA encoding human calcium channel α-1A, β1, β-2, and β-4 subunits, and assays using cells that express the subunits |
02/23/1999 | US5874230 Tumor necrosis factor receptor and dna codes |
02/23/1999 | US5874224 Growth factor receptor binding protein |
02/23/1999 | US5874218 Method for detecting a target compound in a substance using a nucleic acid ligand |
02/23/1999 | US5874215 Amplification of simple sequence repeats |
02/23/1999 | US5874211 Chemokine expressed in eosinophils |
02/23/1999 | US5874209 Regulation of transcription factor, NF-IL6/LAP |
02/23/1999 | US5874088 Oral cholera vaccine from vibrio cholerae |
02/23/1999 | US5874087 Modified plant viruses as vectors |
02/23/1999 | US5874086 Synthetic polypeptide analogs of parathyroid hormone (pth), parathyroid hormone related peptide (pthrp), and of the physiologically active truncated homologs and analogs of pth and pthrp; forming an amphipathic alpha-helix |
02/23/1999 | US5874083 Proteins and complexes for immune response |
02/23/1999 | US5874081 Therapeutic compositions and methods for inhibition and treatment of tumor associated angiogenesis |
02/23/1999 | US5874080 Administering a therapeutic polypeptide antiallergens to inhabit elastase release by neutrophils |
02/23/1999 | US5874077 Human til cells expressing recombinant TNF prohormone |
02/23/1999 | US5874076 Immunomodulators; antitumor,-carcinogenic agents; extracted from a recombinant microorganism; separated from reduced interleukin (cysteine) from the oxidized interleukin (cystine) |
02/23/1999 | CA2133345C A method of limiting the survival of genetically engineered microorganisms in their environment |
02/23/1999 | CA1340403C Human b lymphotropic virus (hblv) isolation and products |